company
as of 2026-07-01Institut National de la Santé Et de la Recherche Médicale, France
at a glance
12 trials sponsored · 23 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
23 assets
Clinical and environmental evaluationClinical and eye movementsComprehensive Assessment of At Risk Mental States (CAARMS)EEGEEG Headset 64 electrodes (BioSemi)ElectroencephalogramElectroretinographyFatigue Management TherapyIllusion taskManual dexterityMonPackOne (Metrovision)Neuropsychological evaluationsNeuropsychological testsOculomotor movementsPsychopathological evaluationsRetinaute (BioSerenity)TMS coupled to EMG recordingbehavioral taskscognitive tasksfMRIsubjective evaluation scalesvirtual reality 1virtual reality 2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
drug
Comprehensive Assessment of At Risk Mental States (CAARMS)
drugDIAGNOSTIC_TEST
EEG
drugPROCEDURE
drug
Electroencephalogram
drugOTHER
Electroretinography
drugDEVICE
Fatigue Management Therapy
drugBEHAVIORAL